BioNTech SE Rightofuse Assets
BioNTech SE (BNTX) had Rightofuse Assets of EUR 210.20 million as of 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Notes
ifrs-full:RightofuseAssets · last filed 2026-03-10
- 2025-12-31: Rightofuse Assets 210.20M EUR.
- 2024-12-31: Rightofuse Assets 248.10M EUR.
- 2023-12-31: Rightofuse Assets 214.40M EUR.
- 2022-12-31: Rightofuse Assets 211.90M EUR.
| Period end | Rightofuse Assets | Rightofuse Assets as first filed |
|---|---|---|
| 2025-12-31 | 210.20M EUR 20-F · filed 2026-03-10 | |
| 2024-12-31 | 248.10M EUR 20-F · filed 2026-03-10 | |
| 2023-12-31 | 214.40M EUR 20-F · filed 2026-03-10 | |
| 2022-12-31 | 211.90M EUR 20-F · filed 2024-03-20 | |
| 2021-12-31 | 197.90M EUR 20-F · filed 2023-03-27 | |
| 2020-12-31 | 99.00M EUR 20-F/A · filed 2022-10-26 | 98.99M EUR 20-F · filed 2021-03-30 |
| 2019-12-31 | 55.02M EUR 20-F · filed 2021-03-30 | |
| 2018-12-31 | 49.77M EUR 20-F · filed 2020-03-31 |